BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35005112)

  • 1. Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma.
    Qiu L; Zhan K; Malale K; Wu X; Mei Z
    Genes Dis; 2022 Jan; 9(1):116-127. PubMed ID: 35005112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel peroxisome-related gene signature predicts clinical prognosis and is associated with immune microenvironment in low-grade glioma.
    Gao D; Zhou Q; Hou D; Zhang X; Ge Y; Zhu Q; Yin J; Qi X; Liu Y; Lou M; Zhou L; Bi Y
    PeerJ; 2024; 12():e16874. PubMed ID: 38406287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma.
    Dai W; Wang J; Wang Z; Xiao Y; Li J; Hong L; Pei M; Zhang J; Yang P; Wu X; Tang W; Jiang X; Jiang P; Xiang L; Li A; Lin J; Liu S; Wang J
    Front Oncol; 2021; 11():767644. PubMed ID: 35004288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
    Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
    BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
    Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
    J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma.
    Song Z; Zhang G; Yu Y; Li S
    Front Genet; 2021; 12():689801. PubMed ID: 34497633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Bai Y; Lin H; Chen J; Wu Y; Yu S
    Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
    [No Abstract]   [Full Text] [Related]  

  • 14. A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma.
    Liang XY; Zhang Y; He YN; Liu XY; Ding ZH; Zhang XD; Dong MY; Du RL
    Front Genet; 2022; 13():888601. PubMed ID: 36171884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma.
    Luo Y; Liu F; Han S; Qi Y; Hu X; Zhou C; Liang H; Zhang Z
    Front Mol Biosci; 2021; 8():670241. PubMed ID: 34095224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
    Du Y; Gao Y
    BMC Cancer; 2020 Sep; 20(1):887. PubMed ID: 32938429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.